Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

HIV self-testing intervention experiences and kit usability: results from a qualitative study among men who have sex with men in the SELPHI (Self-Testing Public Health Intervention) randomized controlled trial in England and Wales.

Witzel TC, Bourne A, Burns FM, Rodger AJ, McCabe L, Gabriel MM, Gafos M, Ward D, Collaco-Moraes Y, Dunn DT, Speakman A, Bonell C, Pebody R, Lampe FC, Harbottle J, Phillips AN, McCormack S, Weatherburn P.

HIV Med. 2020 Mar;21(3):189-197. doi: 10.1111/hiv.12818. Epub 2019 Dec 10.

PMID:
31821698
2.

Investigating Conceptual Models for the Relationship Between Depression and Condomless Sex Among Gay, Bisexual, and Other Men Who have Sex with Men: Using Structural Equation Modelling to Assess Mediation.

Miltz AR, Rodger AJ, Lepri AC, Sewell J, Nwokolo NC, Allan S, Scott C, Ivens D, Lascar M, Speakman A, Phillips AN, Sherr L, Collins S, Elford J, Lampe FC; AURAH Study Group.

AIDS Behav. 2019 Nov 28. doi: 10.1007/s10461-019-02724-0. [Epub ahead of print]

PMID:
31782068
3.

Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.

Lampe FC, Rodger AJ, Burman W, Grulich A, Friedland G, Sadr WE, Neaton J, Corbelli GM, Emery S, Molina JM, Orkin C, Gatell J, Gerstoft J, Ruxrungtham K, Barbosa de Souza M, Phillips AN; INSIGHT START Study Group.

AIDS. 2019 Dec 1;33(15):2337-2350. doi: 10.1097/QAD.0000000000002359.

4.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Shanyinde M, Girardi E, Puoti M, De Luca A, Sighinolfi L, Caterina UF, Caramello P, Lampe FC, D'Arminio Monforte A, Cozzi-Lepri A; ICONA Foundation Study Group.

BMC Public Health. 2019 Oct 15;19(1):1291. doi: 10.1186/s12889-019-7608-1.

5.

Impact of early antiretroviral treatment on sexual behaviour in the INSIGHT Strategic Timing of Anti-Retroviral Treatment (START) Trial.

Lampe FC, Rodger AJ, Burman W, Grulich A, Friedland G, Sadr WE, Neaton J, Corbelli GM, Emery S, Molina JM, Orkin C, Gatell J, Gerstoft J, Ruxrungtham K, Souza MB, Phillips A; INSIGHT START Study Group.

AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002359. [Epub ahead of print]

PMID:
31483377
6.

Pilot phase of an internet-based RCT of HIVST targeting MSM and transgender people in England and Wales: advertising strategies and acceptability of the intervention.

Witzel TC, Gabriel MM, McCabe L, Weatherburn P, Gafos M, Speakman A, Pebody R, Burns FM, Bonell C, Lampe FC, Dunn DT, Ward D, Harbottle J, Phillips AN, McCormack S, Rodger AJ.

BMC Infect Dis. 2019 Aug 8;19(1):699. doi: 10.1186/s12879-019-4247-1.

7.

Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial.

Miltz AR, Lampe FC, Bacchus LJ, McCormack S, Dunn D, White E, Rodger A, Phillips AN, Sherr L, Clarke A, McOwan A, Sullivan A, Gafos M.

BMC Public Health. 2019 Apr 25;19(1):431. doi: 10.1186/s12889-019-6757-6.

8.

Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study.

Sewell J, Cambiano V, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Rodger AJ.

Int J Drug Policy. 2019 Jun;68:54-61. doi: 10.1016/j.drugpo.2019.03.021. Epub 2019 Apr 15.

9.

Associations of depression and anxiety symptoms with sexual behaviour in women and heterosexual men attending sexual health clinics: a cross-sectional study.

Coyle RM, Lampe FC, Miltz AR, Sewell J, Anderson J FRCP, Apea V, Collins S, Dhairyawan R, Johnson AM, Lascar M, Mann S, O'Connell R, Sherr L, Speakman A, Tang A, Phillips AN, Rodger A; AURAH Study Group.

Sex Transm Infect. 2019 Jun;95(4):254-261. doi: 10.1136/sextrans-2018-053689. Epub 2019 Feb 27.

10.

Protocol, rationale and design of SELPHI: a randomised controlled trial assessing whether offering free HIV self-testing kits via the internet increases the rate of HIV diagnosis.

Gabriel MM, Dunn DT, Speakman A, McCabe L, Ward D, Witzel TC, Harbottle J, Collins S, Gafos M, Burns FM, Lampe FC, Weatherburn P, Phillips A, McCormack S, Rodger AJ.

BMC Infect Dis. 2018 Oct 23;18(1):531. doi: 10.1186/s12879-018-3433-x.

11.

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.

Sewell J, Cambiano V, Miltz A, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Hart G, Rodger A.

Sex Transm Infect. 2018 Nov;94(7):494-501. doi: 10.1136/sextrans-2017-053439. Epub 2018 Apr 26.

12.

Ethnicity and sexual risk in heterosexual people attending sexual health clinics in England: a cross-sectional, self-administered questionnaire study.

Coyle RM, Miltz AR, Lampe FC, Sewell J, Phillips AN, Speakman A, Dhar J, Sherr L, Sadiq ST, Taylor S, Ivens DR, Collins S, Elford J, Anderson J, Rodger A; AURAH Study Group.

Sex Transm Infect. 2018 Aug;94(5):384-391. doi: 10.1136/sextrans-2017-053308. Epub 2018 Mar 8.

13.

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study.

Leone S, Shanyinde M, Cozzi Lepri A, Lampe FC, Caramello P, Costantini A, Giacometti A, De Luca A, Cingolani A, Ceccherini Silberstein F, Puoti M, Gori A, d'Arminio Monforte A; ICONA Foundation Cohort Study.

Eur J Clin Microbiol Infect Dis. 2018 May;37(5):871-881. doi: 10.1007/s10096-017-3180-8. Epub 2018 Jan 9.

PMID:
29318459
14.

Eligibility for PrEP among MSM attending GUM clinics in the UK.

Miltz AR, Cambiano V, Lampe FC, Sewell J, Speakman A, Phillips AN, Ivens DR, Asboe D, Collins S, Brady M, Nwokolo NC, Rodger AJ; AURAH Study Group.

Sex Transm Infect. 2017 Dec;93(8):571. doi: 10.1136/sextrans-2017-053268. No abstract available.

PMID:
29175993
15.

Resilience and Physical and Mental Well-Being in Adults with and Without HIV.

McGowan JA, Brown J, Lampe FC, Lipman M, Smith C, Rodger A.

AIDS Behav. 2018 May;22(5):1688-1698. doi: 10.1007/s10461-017-1980-6.

16.

Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme.

Miltz A, Phillips AN, Speakman A, Cambiano V, Rodger A, Lampe FC.

Southampton (UK): NIHR Journals Library; 2017 Oct.

17.

Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK.

Brima N, Lampe FC, Copas A, Gilson R, Williams I, Johnson MA, Phillips AN, Smith CJ.

J Int AIDS Soc. 2017 Aug 30;20(1):21567. doi: 10.7448/IAS.20.21567.

18.

Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmission.

Daskalopoulou M, Rodger AJ, Phillips AN, Sherr L, Elford J, McDonnell J, Edwards S, Perry N, Wilkins E, Collins S, Johnson AM, Burman WJ, Speakman A, Lampe FC; ASTRA Study Group.

Sex Transm Infect. 2017 Dec;93(8):590-598. doi: 10.1136/sextrans-2016-053029. Epub 2017 Jul 5.

19.

Clinically significant depressive symptoms and sexual behaviour among men who have sex with men.

Miltz AR, Rodger AJ, Sewell J, Speakman A, Phillips AN, Sherr L, Gilson RJ, Asboe D, Nwokolo NC, Clarke A, Gompels MM, Allan S, Collins S, Lampe FC; AURAH Study Group.

BJPsych Open. 2017 May 8;3(3):127-137. doi: 10.1192/bjpo.bp.116.003574. eCollection 2017 May.

20.

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.

O'Connor J, Smith C, Lampe FC, Johnson MA, Chadwick DR, Nelson M, Dunn D, Winston A, Post FA, Sabin C, Phillips AN; UK Collaborative HIV Cohort (CHIC) Study.

Lancet HIV. 2017 Jul;4(7):e295-e302. doi: 10.1016/S2352-3018(17)30053-X. Epub 2017 May 4.

21.

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.

Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O'Connell R, Geretti AM, Gilson R, Fisher M, Elford J, Jones M, Collins S, Azad Y, Phillips AN, Speakman A, Johnson MA, Lampe FC.

Lancet Public Health. 2016 Nov;1(1):e26-e36. doi: 10.1016/S2468-2667(16)30002-0.

22.

Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.

Brown J, McGowan JA, Chouial H, Capocci S, Smith C, Ivens D, Johnson M, Sathia L, Shah R, Lampe FC, Rodger A, Lipman M.

HIV Med. 2017 Sep;18(8):604-612. doi: 10.1111/hiv.12497. Epub 2017 Mar 13.

23.

Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.

Sewell J, Miltz A, Lampe FC, Cambiano V, Speakman A, Phillips AN, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Collins S, Hart G, Elford J, Rodger AJ; Attitudes to and Understanding of Risk of Acquisition of HIV (AURAH) Study Group.

Int J Drug Policy. 2017 May;43:33-43. doi: 10.1016/j.drugpo.2017.01.001. Epub 2017 Feb 10.

PMID:
28189979
24.

Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.

Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, Speakman A, Antinori A, Balestra P, Bruun T, Gerstoft J, Nielsen L, Vassilenko A, Collins S, Rodger AJ; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

AIDS Behav. 2018 May;22(5):1573-1583. doi: 10.1007/s10461-017-1683-z.

25.

Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.

Sewell J, Daskalopoulou M, Nakagawa F, Lampe FC, Edwards S, Perry N, Wilkins E, O'Connell R, Jones M, Collins S, Speakman A, Phillips AN, Rodger AJ; Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) Study Group.

HIV Med. 2017 Aug;18(7):463-473. doi: 10.1111/hiv.12477. Epub 2016 Dec 22.

26.

Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.

Daskalopoulou M, Lampe FC, Sherr L, Phillips AN, Johnson MA, Gilson R, Perry N, Wilkins E, Lascar M, Collins S, Hart G, Speakman A, Rodger AJ; ASTRA Study Group.

AIDS Behav. 2017 Jan;21(1):184-195. doi: 10.1007/s10461-016-1541-4.

27.

Age, time living with diagnosed HIV infection, and self-rated health.

McGowan JA, Sherr L, Rodger AJ, Fisher M, Miners A, Anderson J, Johnson MA, Elford J, Collins S, Hart G, Phillips AN, Speakman A, Lampe FC; Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) Study Group.

HIV Med. 2017 Feb;18(2):89-103. doi: 10.1111/hiv.12398. Epub 2016 Jul 7.

28.

Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study).

Sewell J, Speakman A, Phillips AN, Cambiano V, Lampe FC, Gilson R, Asboe D, Nwokolo N, Clarke A, Ogilvy A, Collins S, Rodger AJ.

JMIR Res Protoc. 2016 Jun 15;5(2):e128. doi: 10.2196/resprot.5582.

29.

A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant Characteristics.

Sewell J, Speakman A, Phillips AN, Lampe FC, Miltz A, Gilson R, Asboe D, Nwokolo N, Scott C, Day S, Fisher M, Clarke A, Anderson J, O'Connell R, Apea V, Dhairyawan R, Gompels M, Farazmand P, Allan S, Mann S, Dhar J, Tang A, Sadiq ST, Taylor S, Collins S, Sherr L, Hart G, Johnson AM, Miners A, Elford J, Rodger A.

JMIR Res Protoc. 2016 Apr 18;5(2):e58. doi: 10.2196/resprot.4873.

30.

Sexual behaviour among people with HIV according to self-reported antiretroviral treatment and viral load status.

Lampe FC; Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) Study Group.

AIDS. 2016 Jul 17;30(11):1745-59. doi: 10.1097/QAD.0000000000001104.

31.

Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature review.

Burch LS, Smith CJ, Phillips AN, Johnson MA, Lampe FC.

AIDS. 2016 May 15;30(8):1147-62. doi: 10.1097/QAD.0000000000001068. Review.

PMID:
26919732
32.

Prevalence of recreational drug use is indiscriminate across antiretroviral regimens of differing drug-drug interactions among MSM.

Daskalopoulou M, Rodger AJ, Phillips AN, Speakman A, Lampe FC.

AIDS. 2016 Mar 13;30(5):810-2. doi: 10.1097/QAD.0000000000000994. No abstract available.

PMID:
26913713
33.

Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population.

Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, Anderson J, Collins S, Hart G, Sherr L, Lampe FC; ASTRA (Antiretrovirals, Sexual Transmission and Attitudes) Study.

Lancet HIV. 2014 Oct;1(1):e32-40. doi: 10.1016/S2352-3018(14)70018-9. Epub 2014 Sep 22.

34.

Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study.

Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, Elford J, Johnson MA, Gilson R, Fisher M, Wilkins E, Anderson J, McDonnell J, Edwards S, Perry N, O'Connell R, Lascar M, Jones M, Johnson AM, Hart G, Miners A, Geretti AM, Burman WJ, Lampe FC.

Lancet HIV. 2014 Oct;1(1):e22-31. doi: 10.1016/S2352-3018(14)70001-3. Epub 2014 Sep 7.

35.

Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM.

Phillips AN, Cambiano V, Miners A, Lampe FC, Rodger A, Nakagawa F, Brown A, Gill ON, De Angelis D, Elford J, Hart G, Johnson AM, Lundgren JD, Collins S, Delpech V.

AIDS. 2015 Sep 10;29(14):1855-62. doi: 10.1097/QAD.0000000000000767.

36.

Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?

Saunders P, Goodman AL, Smith CJ, Marshall N, O'Connor JL, Lampe FC, Johnson MA.

HIV Med. 2016 Jan;17(1):18-27. doi: 10.1111/hiv.12272. Epub 2015 Jul 2.

37.

Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Rodger AJ, Lampe FC, Grulich AE, Fisher M, Friedland G, Phanuphak N, Bogner JR, Pereira LC, Rietmeijer C, Burman W, Phillips AN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:64-76. doi: 10.1111/hiv.12235.

38.

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.

Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA.

PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.

39.

Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission.

Rodger AJ, Phillips A, Speakman A, Gilson R, Fisher M, Wilkins E, Anderson J, Johnson M, O'Connell R, Collins S, Elford J, Sherr L, Lampe FC; ASTRA (Antiretrovirals, Sexual Transmission Risk and Attitudes) Study Group.

PLoS One. 2014 May 28;9(5):e97340. doi: 10.1371/journal.pone.0097340. eCollection 2014.

40.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.

O'Connor JL, Smith CJ, Lampe FC, Hill T, Gompels M, Hay P, Chadwick D, Fisher M, Ainsworth J, Gilson R, Mackie N, Anderson J, Orkin C, Nelson M, Kegg S, Leen C, Palfreeman A, Post F, Johnson M, Sabin CA, Phillips AN; UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

AIDS. 2014 Mar 27;28(6):919-24. doi: 10.1097/QAD.0000000000000165.

PMID:
24335482
41.

The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics.

Speakman A, Rodger A, Phillips AN, Gilson R, Johnson M, Fisher M, Ed Wilkins, Anderson J, O'Connell R, Lascar M, Aderogba K, Edwards S, McDonnell J, Perry N, Sherr L, Collins S, Hart G, Johnson AM, Miners A, Elford J, Geretti AM, Burman WJ, Lampe FC.

PLoS One. 2013 Oct 15;8(10):e77230. doi: 10.1371/journal.pone.0077230. eCollection 2013.

42.

Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).

May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D'Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, Lampe FC, Dabis F, Fätkenheuer G, Sterling TR, del Amo J, Gill MJ, Crane HM, Saag MS, Guest J, Brodt HR, Sterne JA; Antiretroviral Cohort Collaboration.

Int J Epidemiol. 2014 Jun;43(3):691-702. doi: 10.1093/ije/dyt010. Epub 2013 Apr 18.

43.

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA.

AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f.

44.

What factors are associated with patient self-reported health status among HIV outpatients? A multi-centre UK study of biomedical and psychosocial factors.

Harding R, Clucas C, Lampe FC, Date HL, Fisher M, Johnson M, Edwards S, Anderson J, Sherr L.

AIDS Care. 2012;24(8):963-71. doi: 10.1080/09540121.2012.668175. Epub 2012 Apr 23.

PMID:
22519889
45.

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy R, Neaton JD; INSIGHT SMART Study Group.

AIDS. 2011 Nov 13;25(17):2133-42. doi: 10.1097/QAD.0b013e32834be088.

46.

Behavioral surveillance study: sexual risk taking behaviour in UK HIV outpatient attendees.

Harding R, Clucas C, Lampe FC, Norwood S, Leake Date H, Fisher M, Johnson M, Edwards S, Anderson J, Sherr L.

AIDS Behav. 2012 Aug;16(6):1708-15. doi: 10.1007/s10461-011-0023-y.

PMID:
21850443
47.

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

Lampe FC, Duprez DA, Kuller LH, Tracy R, Otvos J, Stroes E, Cooper DA, Hoy J, Paton NI, Friis-Møller N, Neuhaus J, Liappis AP, Phillips AN; INSIGHT SMART Study Group.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):275-84.

48.

Self-reported non-adherence to ART and virological outcome in a multiclinic UK study.

Sherr L, Lampe FC, Clucas C, Johnson M, Fisher M, Leake Date H, Anderson J, Edwards S, Smith CJ, Hill T, Harding R.

AIDS Care. 2010 Aug;22(8):939-45. doi: 10.1080/09540121.2010.482126.

PMID:
20574863
49.

Doctor-patient concordance during HIV treatment switching decision-making.

Clucas C, Harding R, Lampe FC, Anderson J, Date HL, Johnson M, Edwards S, Fisher M, Sherr L.

HIV Med. 2011 Feb;12(2):87-96. doi: 10.1111/j.1468-1293.2010.00851.x.

50.

Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse.

Harding R, Lampe FC, Norwood S, Date HL, Clucas C, Fisher M, Johnson M, Edwards S, Anderson J, Sherr L.

Sex Transm Infect. 2010 Dec;86(7):520-4. doi: 10.1136/sti.2009.038505. Epub 2010 Jun 15.

PMID:
20551235

Supplemental Content

Loading ...
Support Center